Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$149.56
+99.55% vs spot
Strong Buy
Spot price
$74.95
Mkt cap $12.98B
subtle cardAnalyst PT consensus
$97.80
+30.49% vs spot
subtle cardMethods covered
14 / 14
12 in blend
subtle cardFootball field
SOLV · fair-value range by method
Method comparison
SOLV · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| Residual income | income | $54.28 | $47.77 – $60.80 | -27.58% | 18.7% | BV 32.74, ROE 30.8% → kₑ | high |
| EVA / MVA | income | $120.36 | $105.91 – $134.80 | +60.58% | 13.1% | IC 9.2B, WACC 6.8% | high |
| Justified P/E | multiple | $0.00 | $0.00 – $0.00 | -100.00% | — | Fair P/E 0.0 (payout 0%, kₑ 7.4%, g -5.0%) | low |
| P/E · sector | multiple | $195.36 | $171.92 – $218.80 | +160.65% | 22.4% | EPS 8.88 × peer P/E 22.0 | med |
| Justified P/B | multiple | $94.70 | $80.50 – $108.91 | +26.35% | 9.3% | Fair P/B 2.89 · ROE 30.8%, kₑ 7.4% | high |
| P/S · sector | multiple | $215.91 | $183.52 – $248.29 | +188.07% | 5.6% | Rev/sh 53.98 × peer P/S 4.00 | med |
| EV / EBITDA | multiple | $220.95 | $194.44 – $247.46 | +194.80% | 18.7% | EBITDA × peer 15.0× − ND 4.2B | high |
| EV / EBIT | multiple | $227.58 | $193.45 – $261.72 | +203.65% | 3.7% | EBIT × peer 18.0× − ND | med |
| EV / Sales | multiple | $156.57 | $133.08 – $180.05 | +108.90% | 3.7% | Sales × peer 3.40× − ND | med |
| Earnings power | intrinsic | $161.35 | $141.99 – $180.71 | +115.27% | 0.9% | NOPAT / WACC, no growth | med |
| Graham revised | intrinsic | $74.46 | $63.29 – $85.63 | -0.65% | 0.9% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $44.40 | $37.74 – $51.06 | -40.76% | 0.9% | PE = g (-5.0) | low |
| Book NAV | asset | $32.74 | $31.10 – $34.37 | -56.32% | 1.9% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $6.64 | $5.64 – $7.64 | -91.14% | — | Cash 100% + non-cash 70% − Liab. | low |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.66)β | × 0.66 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 7.38% |
| Pre-tax cost of debtkd | 6.89% |
| Effective tax ratet | 9.2% |
| After-tax cost of debt | 6.26% |
| Equity weight$5.0B | 50.1% |
| Debt weight$5.0B | 49.9% |
| WACC | 6.82% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | -1.68% |
| Analyst forward EPS growthFMP | -26.29% |
| Historical 5y revenue CAGRFY | 0.47% |
| Historical 5y EPS CAGRFY | 1.19% |
| Sustainable g (ROE × retention)Δ | 30.82% |
| Blended near-term growth (g₀) | -5.00% |
| Terminal growth (gₗ) | 2.00% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2023-12-31)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $97.80
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.